- Brand Name- Cyendiv
- Innovator Brand Name- Ofev & Vargatef
- API- Nintedanib
- Packaging- 60 Capsules
- Strength- 100 mg, 150 mg
- Manufacturer Name- Boehringer Ingelheim
South Delhi Pharma can facilitate the supply of “Cyendiv (Nintedanib)” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Cyendiv (Nintedanib) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Cyendiv is?
Nintedanib is a pharmaceutical drug that inhibits tyrosine kinase and indicated for the treatment of:
- Idiopathic Pulmonary Fibrosis: Nintedanib used to treat the IPF (Idiopathic Pulmonary Fibrosis). It works in order to block such substances that cause IPF.
- Non-Small Cell Lung Cancer (NSCLC): In combination with docetaxel for the patient with locally advanced, metastatic or locally recurring non-small cell lung cancer. Nintedanib can be used as a second-line treatment with a combination of Docetaxel.
What Nintedanib is?
Nintedanib, sold under the brand names Ofev and Vargatef, is an oral medication used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell lung cancer.
In March 2020, it was approved for use in the United States to treat chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait). It is the first treatment for this group of fibrosing lung diseases that worsen over time that was approved by the U.S. Food and Drug Administration (FDA).